A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumabSCIENCE TRANSLATIONAL MEDICINEIF14.62023-02-0114PRE
Pre-Clinical In-Vitro Studies on Parameters Governing Immune Complex FormationPHARMACEUTICSIF5.52022-06-133OAAI
Stability liabilities of biotherapeutic proteins: Early assessment as mitigation strategyJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12021-01-0113PREAI
Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and developmentMABSIF7.32019-09-1218OAAI
Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodiesJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92017-07-0138OAAI
Regulatory Cohesion of Cell Cycle and Cell Differentiation through Inter linked Phosphorylation and Second Messenger NetworksMOLECULAR CELLIF16.62011-08-01164OA
Activation of the diguanylate cyclase PleD by phosphorylation-mediated dimerizationJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92007-10-01202PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向